Teladoc Health Inc. (TDOC)
TDOC trades on NYSE in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1477449/000147744926000012/0001477449-26-000012-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | TDOC on NYSE |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2015 |
| SEC CIK | 0001477449 |
| SEC industry code | Services-Offices & Clinics of Doctors of Medicine |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $2.5B |
| Net income | -$200.3M |
| Operating income | -$263.0M |
| Net margin | -7.9% |
| Operating margin | -10.4% |
| Revenue growth | -1.5% |
| Cash | $781.1M |
| Total assets | $2.9B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.6× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-10-29 |
| Cash and burn | $849.9M cash; operating cash flow $67.1M a quarter. | Report 2026-09-30 |
| Shares outstanding | 182,293,675 (2026-10-23); 177,473,405 a year earlier; 165,557,305 three years earlier. | Cover page 2026-10-23 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Ernst & Young LLP, New York, New York, United States | PCAOB Form AP 2026-03-12 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $69K, sold $2.4M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $605.1M | -$26.9M | $106.5M | $849.9M | $997.6M | $2.5B | 10-Q 2026-10-29 |
| Q2 2026 2026-06-30 | $606.9M | -$38.9M | $64.7M | $774.3M | $996.7M | $2.5B | 10-Q 2026-07-30 |
| Q1 2026 2026-03-31 | $613.8M | -$63.8M | $9.5M | $750.7M | $995.8M | $2.5B | 10-Q 2026-04-30 |
| Q4 2025 2025-12-31 | $642.3M | -$25.1M | $87.7M | $781.1M | $994.9M | $2.5B | 10-K 2026-02-26 |
| Q3 2025 2025-09-30 | $626.4M | -$49.5M | $99.3M | $726.2M | $994.0M | $2.5B | 10-Q 2026-10-29 |
| Q2 2025 2025-06-30 | $631.9M | -$32.7M | $91.4M | $679.6M | $993.2M | $2.5B | 10-Q 2026-07-30 |
| Q1 2025 2025-03-31 | $629.4M | -$93.0M | $15.9M | $1.2B | $1.5B | $2.6B | 10-Q 2026-04-30 |
| Q4 2024 2024-12-31 | $640.5M | -$48.4M | $85.9M | $1.3B | $1.5B | $2.6B | 10-K 2026-02-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2020-11-05 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-10-29 |
| Latest current report | 8-K | 2026-10-28 |
| Latest proxy | DEFA14A | 2026-04-07 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.3% |
| 1 month | +46.7% |
| 3 months | +26.4% |
| Year to date | +25.7% |
| 1 year | +24.5% |
| From 52-week high | -9.5% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| WGS | GeneDx Holdings Corp. | $51.02 | -2.58% | $1.5B |
| USPH | U.S. Physical Therapy Inc. | $99.55 | +0.41% | $1.5B |
| INNV | InnovAge Holding Corp. | $9.58 | +1.16% | $1.3B |
| PNTG | The Pennant Group Inc. Common Stock | $37.03 | +2.66% | $1.3B |
| ADUS | Addus HomeCare Corporation | $124.61 | +1.31% | $2.3B |
| AHCO | AdaptHealth Corp. | $7.73 | +0.91% | $1.1B |
| AVAH | Aveanna Healthcare Holdings Inc. | $11.63 | +1.13% | $2.5B |
| OMDA | Omada Health Inc. | $14.49 | +1.12% | $898.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier